Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited)

Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited) - USD ($)	Total	Common stock	Preferred Stock	Additional paid in capital	Contingently issuable stock	Accumulated deficit
Balance at the beginning (in shares) at Dec. 31, 2017		31,266,989	0
Balance at the beginning at Dec. 31, 2017	$ 27,859,608	$ 31,268	$ 0	$ 83,338,136	$ 2,655,464	$ (58,165,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares pursuant to common stock private placement, net of offering costs (in shares)		1,000,000
Issuance of shares pursuant to common stock private placement, net of offering costs	3,857,106	$ 1,000		3,856,106
Issuance of shares in acquisition of Ichorion assets (in shares)		5,798,735
Issuance of shares in acquisition of Ichorion assets	19,971,554	$ 5,774		19,965,780
Issuance of stock (in shares)		2,349,968
Issuance of stock	0	$ 2,350		2,653,114	(2,655,464)
Exercise of stock options and warrants (in shares)		243,942
Exercise of stock options and warrants	508,745	$ 244		508,501
Shares purchased through employee stock purchase plan (in shares)		20,000
Shares purchased through employee stock purchase plan	8,400	$ 20		8,380
Stock-based compensation	1,796,387			1,796,387
Net loss	(34,493,895)					(34,493,895)
Balance at the end (in shares) at Sep. 30, 2018		40,679,634	0
Balance at the end at Sep. 30, 2018	19,507,905	$ 40,656	$ 0	112,126,404	0	(92,659,155)
Balance at the beginning (in shares) at Jun. 30, 2018		33,790,686	0
Balance at the beginning at Jun. 30, 2018	19,219,416	$ 33,792	$ 0	87,241,204	0	(68,055,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares pursuant to common stock private placement, net of offering costs (in shares)		1,000,000
Issuance of shares pursuant to common stock private placement, net of offering costs	3,857,106	$ 1,000		3,856,106
Issuance of shares in acquisition of Ichorion assets (in shares)		5,798,735
Issuance of shares in acquisition of Ichorion assets	19,971,554	$ 5,774		19,965,780
Exercise of stock options and warrants (in shares)		90,213
Exercise of stock options and warrants	118,272	$ 90		118,182
Stock-based compensation	945,132			945,132
Net loss	(24,603,575)					(24,603,575)
Balance at the end (in shares) at Sep. 30, 2018		40,679,634	0
Balance at the end at Sep. 30, 2018	19,507,905	$ 40,656	$ 0	112,126,404	0	(92,659,155)
Balance at the beginning (in shares) at Dec. 31, 2018		40,804,189	2,857,143
Balance at the beginning at Dec. 31, 2018	20,907,748	$ 40,804	$ 2,857	119,082,157	0	(98,218,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares pursuant to common stock private placement, net of offering costs (in shares)		1,200,000
Issuance of shares pursuant to common stock private placement, net of offering costs	3,737,400	$ 1,200		3,736,200
Issuance of stock (in shares)		1,818,182
Issuance of stock	8,975,960	$ 1,818		8,974,142
Exercise of stock options and warrants (in shares)		74,952
Exercise of stock options and warrants	$ 257,993	$ 75		257,918
Restricted Stock Units vested during period (in shares)	172,500
Restricted Stock Units vested during period	$ 0	173		(173)
Restricted Stock Units withheld for taxes (in shares)	(6,969)
Restricted Stock Units withheld for taxes	$ (33,959)	$ (7)		(33,952)
Shares purchased through employee stock purchase plan (in shares)		43,940
Shares purchased through employee stock purchase plan	127,537	$ 44		127,493
Stock-based compensation	1,942,196			1,942,196
Net loss	(17,693,601)					(17,693,601)
Balance at the end (in shares) at Sep. 30, 2019		44,106,794	2,857,143
Balance at the end at Sep. 30, 2019	18,221,274	$ 44,107	$ 2,857	134,085,981	0	(115,911,671)
Balance at the beginning (in shares) at Jun. 30, 2019		42,898,251	2,857,143
Balance at the beginning at Jun. 30, 2019	17,696,259	$ 42,898	$ 2,857	129,545,721	0	(111,895,217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares pursuant to common stock private placement, net of offering costs (in shares)		1,200,000
Issuance of shares pursuant to common stock private placement, net of offering costs	3,737,400	$ 1,200		3,736,200
Exercise of stock options and warrants (in shares)		539
Exercise of stock options and warrants	$ 1,176	$ 1		1,175
Restricted Stock Units vested during period (in shares)	11,250
Restricted Stock Units vested during period	$ 0	11		(11)
Restricted Stock Units withheld for taxes (in shares)	(3,246)
Restricted Stock Units withheld for taxes	$ (15,901)	$ (3)		(15,898)
Stock-based compensation	818,794			818,794
Net loss	(4,016,454)					(4,016,454)
Balance at the end (in shares) at Sep. 30, 2019		44,106,794	2,857,143
Balance at the end at Sep. 30, 2019	$ 18,221,274	$ 44,107	$ 2,857	$ 134,085,981	$ 0	$ (115,911,671)